2023-07-21 08:00
Biovica, active in cancer monitoring, today announces that the company has received a PLA code from the AMA (American Medical Association), an important milestone in the commercialization of DiviTum® TKa in the United States. The PLA code is a specific...
2023-06-30 08:00
Annual report for the financial year 2022/2023 for Biovica International AB is published today on our website. Biovica International AB - Financial reports Biovica – Treatment decisions with greater confidence Biovica develops and commercializes...
2023-06-21 08:00
Significant events during the first three quarters Significant events during the fourth quarter Significant events after the end of the period Webcast: When: 21 June 2023, 3 PM to 4 PM CET Where: registration via lyyti: https://www.lyyti.in/Q4_Earnings_Call...
2023-06-10 08:30
Biovica today announces that it has signed a provider contract with Contigo Health ConfigureNet™ provider network. This commercial agreement will make Biovica’s blood test, DiviTum® TKa, available to clients and their health plan members...
2023-06-01 16:02
Biovica, active in cancer diagnostics, today announces that a poster with DiviTum® TKa results from the SWOG study S0226 will be presented at the the world’s largest cancer conference, the annual ASCO meeting, on Sunday, June 4. The data supports...
2023-05-17 21:00
Biovica today announces that Biovica Inc, the US laboratory and subsidiary of Biovica International AB, has signed a provider contract with MediNcrease Health Plans, a US, national provider network and provider advocacy firm, to make Biovica’s blood...
2023-05-17 14:15
The extra general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 17 May 2023 and the following resolutions were passed by the meeting. EMPLOYEE STOCK OPTION PROGRAM 2023/2026 FOR SENIOR EXECUTIVES...
2023-04-27 14:30
The shareholders of Biovica International AB, reg. no. 556774-6150, (the "Company") are hereby invited to the extra general meeting to be held on Wednesday 17 May 2023, at 13.00 CET at Baker & McKenzie Advokatbyrå's premises at...
2023-03-28 08:00
Biovica, active in cancer monitoring, today announces that the company has signed a commercial partnership with the European distributor TOROMEDICAL group for the commercialization of the DiviTumTKa test for clinical routine use in the Netherlands and...
>4,500
Numbers of patients in studies
28
Publications
19
Pharma Projects